Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Cancer|August 9, 2022
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcomaJulio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, et al.NPJ Genomic Medicine|November 24, 2023
Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancerIlya G Serebriiskii, Valerii A Pavlov, Grigorii V Andrianov, et al.Cancer Research|March 17, 2007
RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancerSeiji Mabuchi, Deborah A Altomare, Denise C Connolly, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017Hossein Borghaei, Corey J Langer, Michael Millenson, et al.Cancer|October 30, 2003
Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase NetworkNaomi B Haas, Bruce J Giantonio, Samuel Litwin, et al.Cancer Research|May 31, 2002
Cyclin D1 is a candidate oncogene in cutaneous melanomaEdward R Sauter, Un-Cheol Yeo, Andrea von Stemm, et al.The Oncologist|March 29, 2014
A phase I study of temsirolimus and bryostatin-1 in patients with metastatic renal cell carcinoma and soft tissue sarcomaElizabeth R Plimack, Tingting Tan, Yu-Ning Wong, et al.International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boostGary M Freedman, Penny R Anderson, Lori J Goldstein, et al.Gastroenterology|July 26, 2016
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune TolerantWilliam S Mason, Upkar S Gill, Samuel Litwin, et al.Oncoimmunology|August 17, 2017
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptorsAlexander W MacFarlane, Mowafaq Jillab, Mitchell R Smith, et al.Pageof 7